ReP USP - Resultado da busca

Artigo de periodico
Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease (2024)
Espinoza-Chávez, Rocío Marisol ; Rezende Junior, Celso de Oliveira ; Souza, Mariana Laureano de ; Chelucci, Rafael Consolin; Duarte, Simone Michelan ; Krogh, Renata ; Ferreira, Leonardo Luiz Gomes ; Valli, Marilia ; Oliveira, Aldo Sena de ; Andricopulo, Adriano Defini ; Dias, Luiz Carlos
Source: ChemMedChem. Unidade: IFSC
Subjects: TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS, DOENÇAS PARASITÁRIAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESPINOZA-CHÁVEZ, Rocío Marisol et al. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease. ChemMedChem, v. 19, n. 20, p. e202400293, 2024Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202400293. Acesso em: 03 nov. 2024.
APA
Espinoza-Chávez, R. M., Rezende Junior, C. de O., Souza, M. L. de, Chelucci, R. C., Duarte, S. M., Krogh, R., et al. (2024). Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease. ChemMedChem, 19( 20), e202400293. doi:10.1002/cmdc.202400293
NLM
Espinoza-Chávez RM, Rezende Junior C de O, Souza ML de, Chelucci RC, Duarte SM, Krogh R, Ferreira LLG, Valli M, Oliveira AS de, Andricopulo AD, Dias LC. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease [Internet]. ChemMedChem. 2024 ; 19( 20): e202400293.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/cmdc.202400293
Vancouver
Espinoza-Chávez RM, Rezende Junior C de O, Souza ML de, Chelucci RC, Duarte SM, Krogh R, Ferreira LLG, Valli M, Oliveira AS de, Andricopulo AD, Dias LC. Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease [Internet]. ChemMedChem. 2024 ; 19( 20): e202400293.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/cmdc.202400293
Artigo de periodico
Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics (2022)
Pauli, Ivani; Rezende Junior, Celso de Oliveira ; Slafer, Brian W.; Dessoy, Marco A.; Souza, Mariana Laureano de ; Ferreira, Leonardo Luiz Gomes ; Adjanohun, Abraham L. M.; Ferreira, Rafaela S.; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Duarte, Simone Michelan ; Del Pintor, Ricardo Vaz; Silva, Fernando B. R. da; Cruz, Fabio C.; Dias, Luiz C.; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULI, Ivani et al. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, v. 12, n. Ja 2022, p. 774069-1-774069-21 + supplementary material, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.774069. Acesso em: 03 nov. 2024.
APA
Pauli, I., Rezende Junior, C. de O., Slafer, B. W., Dessoy, M. A., Souza, M. L. de, Ferreira, L. L. G., et al. (2022). Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, 12( Ja 2022), 774069-1-774069-21 + supplementary material. doi:10.3389/fphar.2021.774069
NLM
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Vancouver
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Artigo de periodico
Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity (2019)
Ferreira, Rafael A. A.; Pauli, Ivani; Sampaio, Thiago S.; Souza, Mariana Laureano de; Ferreira, Leonardo Luiz Gomes ; Magalhães, Luma Godoy; Rezende Junior, Celso O.; Ferreira, Rafaela S.; Andricopulo, Renata Krogh; Dias, Luiz C.; Andricopulo, Adriano Defini
Source: Frontiers in Chemistry. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael A. A. et al. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity. Frontiers in Chemistry, v. No 2019, p. 798-1-798-21, 2019Tradução . . Disponível em: https://doi.org/10.3389/fchem.2019.00798. Acesso em: 03 nov. 2024.
APA
Ferreira, R. A. A., Pauli, I., Sampaio, T. S., Souza, M. L. de, Ferreira, L. L. G., Magalhães, L. G., et al. (2019). Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity. Frontiers in Chemistry, No 2019, 798-1-798-21. doi:10.3389/fchem.2019.00798
NLM
Ferreira RAA, Pauli I, Sampaio TS, Souza ML de, Ferreira LLG, Magalhães LG, Rezende Junior CO, Ferreira RS, Andricopulo RK, Dias LC, Andricopulo AD. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity [Internet]. Frontiers in Chemistry. 2019 ; No 2019 798-1-798-21.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fchem.2019.00798
Vancouver
Ferreira RAA, Pauli I, Sampaio TS, Souza ML de, Ferreira LLG, Magalhães LG, Rezende Junior CO, Ferreira RS, Andricopulo RK, Dias LC, Andricopulo AD. Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity [Internet]. Frontiers in Chemistry. 2019 ; No 2019 798-1-798-21.[citado 2024 nov. 03 ] Available from: https://doi.org/10.3389/fchem.2019.00798
Trabalho de evento-resumo
Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach (2019)
Rezende Junior, Celso; Souza, Mariana L.; Chavez, Rocio; Ferreira, Rafaela S.; Slafer, Brian W.; Cruz, Fábio C.; Ferreira, Leonardo Luiz Gomes ; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Oliva, Glaucius ; Andricopulo, Adriano Defini ; Dias, Luiz C.
Source: Anais eletrônicos. Conference titles: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REZENDE JUNIOR, Celso et al. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach. 2019, Anais.. Campinas: Galoá, 2019. Disponível em: https://proceedings.science/p/107156. Acesso em: 03 nov. 2024.
APA
Rezende Junior, C., Souza, M. L., Chavez, R., Ferreira, R. S., Slafer, B. W., Cruz, F. C., et al. (2019). Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach. In Anais eletrônicos. Campinas: Galoá. Recuperado de https://proceedings.science/p/107156
NLM
Rezende Junior C, Souza ML, Chavez R, Ferreira RS, Slafer BW, Cruz FC, Ferreira LLG, Magalhães LG, Andricopulo RK, Oliva G, Andricopulo AD, Dias LC. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach [Internet]. Anais eletrônicos. 2019 ;[citado 2024 nov. 03 ] Available from: https://proceedings.science/p/107156
Vancouver
Rezende Junior C, Souza ML, Chavez R, Ferreira RS, Slafer BW, Cruz FC, Ferreira LLG, Magalhães LG, Andricopulo RK, Oliva G, Andricopulo AD, Dias LC. Carbamoylimidazoles as potent cruzain inhibitors with in vitro and in vivo trypanocidal activity: a structure-based drug design approach [Internet]. Anais eletrônicos. 2019 ;[citado 2024 nov. 03 ] Available from: https://proceedings.science/p/107156

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies